WallStreetZenWallStreetZen

NASDAQ: TSBX
Turnstone Biologics Corp Stock Ownership - Who owns Turnstone Biologics?

Insider buying vs selling

Have Turnstone Biologics Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Versant Ventures V LLC10% Owner2023-07-2515,028$12.00
$180.34kBuy
Versant Ventures V LLC10% Owner2023-07-25197,458$12.00
$2.37MBuy
Davis JerelDirector2023-07-256,575$12.00
$78.90kBuy
Davis JerelDirector2023-07-2515,028$12.00
$180.34kBuy
Davis JerelDirector2023-07-25197,458$12.00
$2.37MBuy
Davis JerelDirector2023-07-255,939$12.00
$71.27kBuy
Versant Ventures V LLC10% Owner2023-07-255,939$12.00
$71.27kBuy
Versant Ventures V LLC10% Owner2023-07-256,575$12.00
$78.90kBuy
Orbimed Advisors LLCDirector2023-07-20416,666$12.00
$5.00MBuy
Rishi GuptaDirector2023-07-20416,666$12.00
$5.00MBuy

1 of 1

TSBX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TSBX insiders and whales buy or sell their stock.

TSBX Shareholders

What type of owners hold Turnstone Biologics Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Versant Ventures V LLC14.64%3,381,692$9.81MInsider
Davis Jerel14.64%3,381,692$9.81MInsider
Rishi Gupta13.42%3,099,265$8.99MInsider
Orbimed Advisors LLC13.42%3,099,265$8.99MInsider
Orbimed Advisors LLC13.42%3,099,265$8.99MInstitution
Fmr LLC11.02%2,546,661$7.39MInstitution
Fmr LLC4.91%1,133,987$3.29MInsider
Bank Of America Corp3.96%914,058$2.65MInstitution
Point72 Asset Management LP3.61%833,333$2.42MInstitution
Eventide Asset Management LLC3.07%708,317$2.05MInstitution

1 of 3

TSBX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TSBX46.24%53.76%Net Buying
MNOV9.85%89.10%
RLYB43.27%56.73%
IKNA66.60%18.22%
DTIL53.55%46.45%Net Selling

Turnstone Biologics Stock Ownership FAQ

Who owns Turnstone Biologics?

Turnstone Biologics (NASDAQ: TSBX) is owned by 52.49% institutional shareholders, 61.02% Turnstone Biologics insiders, and 0.00% retail investors. Versant Ventures V LLC is the largest individual Turnstone Biologics shareholder, owning 3.38M shares representing 14.64% of the company. Versant Ventures V LLC's Turnstone Biologics shares are currently valued at $9.33M.

If you're new to stock investing, here's how to buy Turnstone Biologics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.